Journal
DIABETOLOGIA
Volume 65, Issue 1, Pages 140-149Publisher
SPRINGER
DOI: 10.1007/s00125-021-05584-3
Keywords
Diabetic nephropathy; Metabolite profiling; NMR; Progression; Type 1 diabetes
Categories
Funding
- University of Helsinki
- Wilhelm and Else Stockmann Foundation
- Liv och Halsa Society
- Helsinki University Hospital Research Funds [TYH2018207]
- Novo Nordisk Foundation [NNF OC0013659]
- Sigrid Juselius Foundation
- Academy of Finland [299200, 316664]
- Helsinki University Central Hospital
- Folkhalsan Research Foundation
Ask authors/readers for more resources
This study found that branched-chain amino acids and other urinary metabolites were associated with the progression of diabetic nephropathy, independent of baseline albuminuria and chronic kidney disease. Additionally, different associations were observed for overall progression, normoalbuminuria, and macroalbuminuria progression.
Aims/hypothesis This prospective, observational study examines associations between 51 urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 diabetes by employing an automated NMR metabolomics technique suitable for large-scale urine sample collections. Methods We collected 24-h urine samples for 2670 individuals with type 1 diabetes from the Finnish Diabetic Nephropathy study and measured metabolite concentrations by NMR. Individuals were followed up for 9.0 +/- 5.0 years until their first sign of progression of diabetic nephropathy, end-stage kidney disease or study end. Cox regressions were performed on the entire study population (overall progression), on 1999 individuals with normoalbuminuria and 347 individuals with macroalbuminuria at baseline. Results Seven urinary metabolites were associated with overall progression after adjustment for baseline albuminuria and chronic kidney disease stage (p < 8 x 10(-4)): leucine (HR 1.47 [95% CI 1.30, 1.66] per 1-SD creatinine-scaled metabolite concentration), valine (1.38 [1.22, 1.56]), isoleucine (1.33 [1.18, 1.50]), pseudouridine (1.25 [1.11, 1.42]), threonine (1.27 [1.11, 1.46]) and citrate (0.84 [0.75, 0.93]). 2-Hydroxyisobutyrate was associated with overall progression (1.30 [1.16, 1.45]) and also progression from normoalbuminuria (1.56 [1.25, 1.95]). Six amino acids and pyroglutamate were associated with progression from macroalbuminuria. Conclusions/interpretation Branched-chain amino acids and other urinary metabolites were associated with the progression of diabetic nephropathy on top of baseline albuminuria and chronic kidney disease. We found differences in associations for overall progression and progression from normo- and macroalbuminuria. These novel discoveries illustrate the utility of analysing urinary metabolites in entire population cohorts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available